Linzagolix for treating moderate to severe symptoms of uterine fibroids: a single technology appraisal
Linzagolix for treating moderate to severe symptoms of uterine fibroids: a single technology appraisal
This report is a critique of the company’s submission (CS) to NICE from Theramex on the clinical effectiveness and cost effectiveness of linzagolix for treating moderate to severe symptoms of uterine fibroids. It identifies the strengths and weaknesses of the CS.
Southampton Health Technology Assessments Centre
Woods, Lois
8149aa11-7664-4052-a18b-98f7bde83180
Kalita, Neelam
da42f168-a3cc-44c9-bafb-2801ff57914b
Hawa, Asyl
64ce4257-6176-4a4e-bce5-5e1147377355
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Frampton, Geoff
26c6163c-3428-45b8-b8b9-92091ff6c69f
2023
Woods, Lois
8149aa11-7664-4052-a18b-98f7bde83180
Kalita, Neelam
da42f168-a3cc-44c9-bafb-2801ff57914b
Hawa, Asyl
64ce4257-6176-4a4e-bce5-5e1147377355
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Frampton, Geoff
26c6163c-3428-45b8-b8b9-92091ff6c69f
Woods, Lois, Kalita, Neelam, Hawa, Asyl, Scott, David Alexander and Frampton, Geoff
(2023)
Linzagolix for treating moderate to severe symptoms of uterine fibroids: a single technology appraisal
Southampton Health Technology Assessments Centre
156pp.
Record type:
Monograph
(Project Report)
Abstract
This report is a critique of the company’s submission (CS) to NICE from Theramex on the clinical effectiveness and cost effectiveness of linzagolix for treating moderate to severe symptoms of uterine fibroids. It identifies the strengths and weaknesses of the CS.
Text
Linzagolix EAG report
- Version of Record
Available under License Other.
More information
Published date: 2023
Identifiers
Local EPrints ID: 495567
URI: http://eprints.soton.ac.uk/id/eprint/495567
PURE UUID: 56b2c5b5-56ad-409e-a8f7-f650ed3132ef
Catalogue record
Date deposited: 18 Nov 2024 17:41
Last modified: 25 Jan 2025 03:06
Export record
Contributors
Author:
David Alexander Scott
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics